直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Article

D. Mass. Patent Litigation Update: July 2026

August 27, 2026

By Matthew C. Berntsen; Jamal L. Perry

This is part of a series of articles discussing recent orders of interest issued in patent cases by the United States District Court for the District of Massachusetts.


In InMode Ltd. v. BTL Industries, Inc. d/b/a BTL Aesthetics, No. 24-cv-12955-PBS, Judge Saris issued an order construing disputed claim terms in a patent directed to non-invasive, non-ablative methods for remodeling or tightening vaginal tissue using radiant energy. Two of those terms are as follows:

Select Disputed Claim Terms

1.     “Heating the target tissue”

The Court rejected both parties’ proposed temperature limitations as improper. The Court explained that the claims do not, on their face, impose any temperature restrictions. Additionally, the Court noted that temperature limitations are expressly recited in various dependent claims and that, under the doctrine of claim differentiation, the independent claims are presumed to be broader. Furthermore, neither party demonstrated that the specification clearly intended to limit “heating the target tissue” to anything beyond its plain language.

Therefore, the Court construed “heating the target tissue” as “making the target tissue hotter.”

2.     “Remodeling the therapeutic zone of target tissue”

The Court noted the parties’ agreement that “‘remodeling’ effectively means tightening or contracting the target tissue” and rejected InMode’s proposal to add the limitation “without substantially affecting the epithelium overlying the target tissue” as unsupported by the intrinsic record and in tension with dependent claims that recite epithelium maintenance as a separate step.

Accordingly, the Court agreed with BTL and construed “remodeling the therapeutic zone of target tissue” as “causing a zone of tissue within the target tissue to tighten or contract by heating the zone of tissue to a therapeutic temperature.”

Tags

Article Series: D. Mass. Patent Litigation Update, District of Massachusetts, claim construction

Related Practices

Global IP Enforcement, Litigation, and Trials

Patent Litigation and Trials

Related Industries

Life Sciences

Medical Device and Diagnostics

Related Offices

Boston, MA

Related Professionals

Matthew C. Berntsen
Partner
Boston, MA
+1 617 646 1618
Email
Jamal L. Perry
Associate
Boston, MA
+1 617 646 1687
Email

Copyright © Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. This article is for informational purposes, is not intended to constitute legal advice, and may be considered advertising under applicable state laws. This article is only the opinion of the authors and is not attributable to Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, or the firm’s clients.

Related Insights

Conference

Patent Litigation Europe 2027

January 18-20, 2027

Amsterdam

Reception

2026 IPO Education Foundation Awards Dinner

December 15, 2026

Washington, DC

Panel Discussion

2026 Advanced Patent Law Institute

December 3-4, 2026

Stanford

Conference

IPBC Asia 2026

November 17-19, 2026

Tokyo

Conference

IAM Live: Navigating the UPC 2026

November 4, 2026

Paris

Conference

Life Sciences Patent Network North America Fall 2026

November 2-3, 2026

San Francisco

Conference

4th Global Patent Litigation FORUM

October 29, 2026

Munich

Conference

2026 AIPLA Annual Meeting

October 29-31, 2026

Washington, DC

Conference

2026 EDTX Bench Bar Conference

October 28-30, 2026

Fort Worth

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP